Vestal Point Capital, LP

CIK 0001974915 • 6 13F filings • May 15, 2025 – Aug 14, 2026

Import this data to Google Sheets with:

=jivedata("vestal-point-capital-lp","13f")

Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".

Filer information

Filed by: Vestal Point Capital, LP, Partner, COO and CCO
Address: 632 BROADWAY, SUITE 602, NEW YORK, NY, 10012
Phone: 6469894002
AUM: $2.94B

AUM over time

$4.28B latest

Sector allocation over time

Past 5 quarters

Q4 2025

Q3 2025

Q2 2026

Q2 2025

Q1 2026

HealthcareOther

Holdings by filing

Portfolio value: $2.94B76 positionsView on SEC.gov

			% of Portfolio
Abbott Laboratories	COM	$75.2M	2.6%Prev: 1.5%	600,000 SH	Increased+350,000 SH
Abivax SA	SPONSORED ADS	$256.2M	8.7%Prev: 3.8%	1,900,000 SH	Increased+900,000 SH
Agios Pharmaceuticals Inc	COM	$8.8M	0.3%Prev: 0.2%	325,000 SH	Increased+198,000 SH
Alcon AG	ORD SHS	$87.1M	3.0%Prev: 3.7%	1,105,000 SH	Increased+5,000 SH
Alector Inc	COM	$1.2M	0.0%Prev: 0.1%	755,000 SH	Decreased-225,000 SH
Alto Neuroscience Inc	COM SHS	$44.2M	1.5%Prev: 0.2%	2,485,000 SH	Increased+1,535,000 SH
Apogee Therapeutics Inc	COM	$41.5M	1.4%Prev: 0.8%	550,000 SH	Increased+125,000 SH
Arcellx Inc	COMMON STOCK	$190.7M	6.5%Prev: 4.6%	2,925,000 SH	Increased+1,675,000 SH
Arrowhead Pharmaceuticals Inc	COM	$59.8M	2.0%	900,000 SH	New
Ascendis Pharma A/S	SPONSORED ADR	$37.3M	1.3%Prev: 5.4%	175,000 SH	Decreased-425,000 SH
Axsome Therapeutics Inc	COM	$38.4M	1.3%Prev: 0.8%	210,000 SH	Increased+60,000 SH
Beta Bionics Inc	COM	$18.3M	0.6%Prev: 0.5%	600,000 SH	Increased
Bicara Therapeutics Inc	COM	$60.2M	2.0%Prev: 3.6%	3,575,000 SH	Decreased-1,525,000 SH
BioCryst Pharmaceuticals Inc	COM	$17.6M	0.6%	2,250,000 SH	New
BioMarin Pharmaceutical Inc	COM	$178.3M	6.1%Prev: 2.0%	3,000,000 SH	Increased+2,170,000 SH
Black Diamond Therapeutics Inc	COM	$2.1M	0.1%Prev: 0.9%	870,000 SH	Decreased-4,680,000 SH
Bristol-Myers Squibb Co	COM	$13.5M	0.5%	250,000 SH	New
Celldex Therapeutics Inc	COM NEW	$31.6M	1.1%Prev: 1.4%	1,165,000 SH	Increased-40,000 SH
Crescent Biopharma Inc	COM	$17.8M	0.6%	1,500,000 SH	New
Day One Biopharmaceuticals Inc	COM	$48.5M	1.6%Prev: 0.9%	5,200,000 SH	Increased+2,525,000 SH
DBV Technologies SA	SPONSORED ADS	$5.8M	0.2%	300,000 SH	New
Definium Therapeutics Inc	COM NEW	$8.5M	0.3%	637,000 SH	New
Denali Therapeutics Inc	COM	$7.7M	0.3%	465,000 SH	New
Dexcom Inc	COM	$84.6M	2.9%Prev: 2.0%	1,275,000 SH	Increased+625,000 SH
Disc Medicine Inc	COM	$58.4M	2.0%Prev: 1.5%	735,000 SH	Increased+235,000 SH
Dyne Therapeutics Inc	COM	$2.3M	0.1%Prev: 1.6%	120,000 SH	Decreased-2,655,000 SH
Engene Holdings Inc	COM	$9.5M	0.3%Prev: 0.1%	1,055,000 SH	Increased+685,000 SH
Enliven Therapeutics Inc	COM	$59.0M	2.0%Prev: 1.1%	3,830,000 SH	Increased+2,670,000 SH
Fate Therapeutics Inc	COM	$1.7M	0.1%Prev: 0.1%	1,725,000 SH	Decreased-790,000 SH
Fulcrum Therapeutics Inc	COM	$10.7M	0.4%	950,000 SH	New
Geron Corp	COM	$14.9M	0.5%Prev: 1.1%	11,320,000 SH	Decreased-5,905,000 SH
Gilead Sciences Inc	COM	$6.1M	0.2%	50,000 SH	New
Globus Medical Inc	CL A	$111.3M	3.8%Prev: 3.2%	1,275,000 SH	Increased+25,000 SH
Immatics NV	SHS	$64.3M	2.2%Prev: 2.4%	6,125,000 SH	Increased-225,000 SH
Immunocore Holdings PLC	ADS	$20.3M	0.7%	585,000 SH	New
Invesco QQQ Trust Series 1	UNIT SER 1	$215.0M	7.3%	350,000 SH	New
Jazz Pharmaceuticals PLC	SHS USD	$49.3M	1.7%Prev: 3.0%	290,000 SH	Decreased-210,000 SH
KalVista Pharmaceuticals Inc	COM	$30.5M	1.0%Prev: 0.4%	1,890,000 SH	Increased+1,140,000 SH
Lantheus Holdings Inc	COM	$24.0M	0.8%Prev: 0.4%	360,000 SH	Increased+190,000 SH
LENZ Therapeutics Inc	COM	$4.4M	0.1%	275,000 SH	New
Lexeo Therapeutics Inc	COM	$44.4M	1.5%Prev: 1.0%	4,475,000 SH	Increased+1,225,000 SH
MacroGenics Inc	COM	$451K	0.0%Prev: 0.0%	280,000 SH	Decreased
MapLight Therapeutics Inc	COM	$6.8M	0.2%	385,000 SH	New
Merck & Co Inc	COM	$81.6M	2.8%	775,000 SH	New
Mirum Pharmaceuticals Inc	COM	$5.2M	0.2%	66,000 SH	New
Monte Rosa Therapeutics Inc	COM	$12.2M	0.4%Prev: 0.3%	775,000 SH	Increased-25,000 SH
Myriad Genetics Inc	COM	$7.5M	0.3%Prev: 0.2%	1,223,000 SH	Increased+623,000 SH
Novocure Ltd	ORD SHS	$6.8M	0.2%Prev: 0.2%	525,000 SH	Increased+125,000 SH
Nurix Therapeutics Inc	COM	$89.0M	3.0%Prev: 1.4%	4,690,000 SH	Increased+1,215,000 SH
Nuvalent Inc	COM	$4.6M	0.2%Prev: 4.3%	46,000 SH	Decreased-1,054,000 SH
Nyxoah SA	SHS	$5.1M	0.2%Prev: 0.2%	1,107,000 SH	Decreased-413 SH
Olema Pharmaceuticals Inc	COM	$41.3M	1.4%	1,650,000 SH	New
OnKure Therapeutics Inc	COM CL A	$1.8M	0.1%Prev: 0.1%	635,000 SH	Increased
Passage Bio Inc	COM NEW	$3.6M	0.1%Prev: 0.1%	305,000 SH	Increased
Penumbra Inc	COM	$15.5M	0.5%	50,000 SH	New
Rapport Therapeutics Inc	COM	$33.7M	1.1%Prev: 1.3%	1,110,000 SH	Increased+160,000 SH
REGENXBIO Inc	COM	$490K	0.0%	34,000 SH	New
Repligen Corp	COM	$13.6M	0.5%Prev: 2.4%	83,000 SH	Decreased-317,000 SH
Revolution Medicines Inc	COM	$23.5M	0.8%Prev: 1.3%	295,000 SH	Decreased-335,000 SH
Rezolute Inc	COM NEW	$4.0M	0.1%	1,686,000 SH	New
Savara Inc	COM	$9.7M	0.3%Prev: 0.6%	1,606,000 SH	Decreased-2,409,000 SH
Scholar Rock Holding Corp	COM	$30.8M	1.0%Prev: 2.5%	700,000 SH	Decreased-800,000 SH
Solid Biosciences Inc	COM NEW	$32.8M	1.1%Prev: 0.8%	5,815,000 SH	Increased+2,840,000 SH
Structure Therapeutics Inc	SPONSORED ADS	$2.4M	0.1%	35,000 SH	New
Sutro Biopharma Inc	COM SHS	$2.8M	0.1%	243,000 SH	New
Taysha Gene Therapies Inc	COM SHS	$75.6M	2.6%Prev: 0.8%	13,750,000 SH	Increased+8,250,000 SH
Tectonic Therapeutic Inc	COM	$6.8M	0.2%	328,000 SH	New
Tenax Therapeutics Inc	COM NEW	$651K	0.0%Prev: 0.0%	53,439 SH	Increased
Terns Pharmaceuticals Inc	COM	$181.8M	6.2%	4,500,000 SH	New
Tyra Biosciences Inc	COM	$63.8M	2.2%Prev: 1.5%	2,425,000 SH	Increased
Upstream Bio Inc	COM	$19.5M	0.7%	720,000 SH	New
Vera Therapeutics Inc	CL A	$27.9M	0.9%Prev: 1.0%	550,000 SH	Increased-210,000 SH
Voyager Therapeutics Inc	COM	$5.8M	0.2%Prev: 0.3%	1,475,000 SH	Decreased
Xenon Pharmaceuticals Inc	COM	$26.9M	0.9%Prev: 2.0%	600,000 SH	Decreased-500,000 SH
Zimmer Biomet Holdings Inc	COM	$13.5M	0.5%	150,000 SH	New
Zymeworks Inc	COM	$22.8M	0.8%Prev: 1.4%	865,000 SH	Decreased-900,000 SH

Sold (vs prior filing)

Amicus Therapeutics Inc — $76.8M
Applied Therapeutics Inc — $8.6M
Arcus Biosciences Inc — $3.4M
Arcutis Biotherapeutics Inc — $3.8M
Astria Therapeutics Inc — $36.1M
Becton Dickinson & Co — $60.8M
Belite Bio Inc — $23.1M
Biogen Inc — $38.5M
Biohaven Ltd — $10.5M
Bruker Corp — $14.3M
CG Oncology Inc — $7.0M
Cidara Therapeutics Inc — $38.3M
Crinetics Pharmaceuticals Inc — $31.2M
Cytokinetics Inc — $39.8M
Danaher Corp — $29.7M
Dianthus Therapeutics Inc — $46.4M
Establishment Labs Holdings In — $4.1M
Exact Sciences Corp — $4.1M
GSK PLC — $5.4M
Inspire Medical Systems Inc — $10.0M
… and 10 more

All filings

Open a filing on Jive Data

Filing Date	Quarter	Form	Accession	Portfolio	Filing
Feb 17, 2026	Q4 2025	13F-HR	0001974915-26-000002	$2.94B	View
Nov 14, 2025	Q3 2025	13F-HR	0001974915-25-000008	$2.21B	View
Aug 14, 2026	Q2 2026